Knowledge hub

Prof Osmo Tervonen is a professor and a senior radiologist at Oulu University Hospital in Finland. He is also a partner in Parasmed - a Nairobi based medical device distributor, which provides access to emerging medical technologies to the countries in the East African region. In his interview with Oxipit, prof Tervonen shares his views on AI in healthcare and AI’s role in the field of value based medicine.

AI medical imaging company Oxipit appointed Dany Chammas as their new Chief Commercial Officer. With more than 15 years of experience in top tier medical imaging companies, Dany will join the Executive Team to increase Oxipit’s visibility and accelerate business growth.

In the last post we highlighted how AI medical imaging solutions can serve as ‘a second set of eyes’ reducing the risk of overlooked findings. Operating in near-real time, they can affect patient treatment decisions, mitigating the risk of missed potentially life-threatening pathologies.

In an interview with Oxipit Dr Erik Ranschaert singled out how AI and a radiologist operate as a team to arrive at a more precise diagnosis. In such clinical workflow, AI medical imaging solutions provide a ‘second set of eyes’ and mitigates the risk of overlooked findings.

Dr Erik Ranschaert is one of the key AI medical imaging experts in Europe. He is Digital Doctor at ETZ Hospital in Tilburg, responsible for developing a hospital-wide AI infrastructure. In this interview with Oxipit, Erik shares his views on AI tool adoption, future of radiology and why we should learn and unlearn.

As we are building our AI tools in Europe, multi-lingual availability is their integral feature. Our first product Oxipit ChestEye produces radiological reports (report out) in 14 languages. In addition, our platform can ingest radiological reports (report in) in any world language.

ChestLink analytical dashboard is an integral part of autonomous AI operations. The dashboard helps to ensure transparency, accountability and traceability of every taken action.

Autonomous AI medical imaging platform deployment follows a three-stage framework. Ensuring process clarity, transparency, accountability and decision traceability is no less important than the performance of the AI autonomous product itself.

ChestLink, the first autonomous medical imaging application, produces automated reports for healthy patients. Learn why we have selected healthy patient report automation as a viable first step for autonomous operations.

It is safe to say that in developed countries the radiology departments are understaffed by 1/3. Moreover, the report by World Health Organization states that 2/3 of the world population does not have access to diagnostic medical imaging.